In this light, it seems interesting that anti-TSLP monoclonal antibody therapy reduced exacerbations in patients with severe asthma with non-T2 inflammation, and thus TSLP may play a role in patients with little or no T2 inflammation [139]. Here, TSLP is linked to asthma.